ID

31996

Beskrivning

EUropean Pharmacogenetics of AntiCoagulant Therapy - Phenprocoumon; ODM derived from: https://clinicaltrials.gov/show/NCT01119274 Sponsor: Utrecht Institute for Pharmaceutical Sciences Collaborators: Utrecht University Leiden University Medical Center Erasmus Medical Center University of Ulm Newcastle University University of Liverpool LGC Limited Uppsala University Democritus University of Thrace Elisabethinen Hospital Information provided by (Responsible Party): Anke-Hilse Maitland-van der Zee, Utrecht Institute for Pharmaceutical Sciences

Länk

https://clinicaltrials.gov/show/NCT01119274

Nyckelord

Versioner (1)
  1. 2018-10-10 2018-10-10 -
Rättsinnehavare

Anke-Hilse Maitland-van der Zee, PharmD, PhD, Utrecht Institute for Pharmaceutical Sciences

Uppladdad den

10 oktober 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY-NC 3.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Venous Thromboembolism (VTE) Phenprocoumon NCT01119274

Engelsk

Eligibility Venous Thromboembolism (VTE) Phenprocoumon NCT01119274

1 Formulär  
Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
Beskrivning

Venous thromboembolism, atrial fibrillation requiring coumarin therapy, target inr in the low intensity range

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1861172
UMLS CUI [1,2]
C0686904
UMLS CUI [1,3]
C0010206
UMLS CUI [2,1]
C0004238
UMLS CUI [2,2]
C0686904
UMLS CUI [2,3]
C0010206
UMLS CUI [3,1]
C1521840
UMLS CUI [3,2]
C0525032
age ≥ 18 years
Beskrivning

Age

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
ability to attend scheduled visits
Beskrivning

Ability to attend scheduled visits

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2827364
UMLS CUI [1,2]
C0085732
signed informed consent
Beskrivning

Informed consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
presence of a mechanical heart valve
Beskrivning

Presence of a mechanical heart valve

Datatyp

boolean

Alias
UMLS CUI [1]
C0493527
severe cognitive impairment
Beskrivning

Severe cognitive impairment

Datatyp

boolean

Alias
UMLS CUI [1]
C3554639
known genotype cyp2c9 or vkorc1 at start of the study
Beskrivning

Known genotype cyp2c9 or vkorc1

Datatyp

boolean

Alias
UMLS CUI [1]
C1332829
UMLS CUI [2]
C1428184
previous or current treatment with any coumarin
Beskrivning

Previous or current treatment with any coumarin

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0010206
UMLS CUI [1,2]
C2827774
UMLS CUI [2,1]
C0010206
UMLS CUI [2,2]
C1514463
pregnancy or lactation
Beskrivning

Pregnancy or lactation

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0022925
non-eligible subject
Beskrivning

Ineligibility

Datatyp

boolean

Alias
UMLS CUI [1]
C1512714
Tillbaka till toppen

Similar models

Eligibility Venous Thromboembolism (VTE) Phenprocoumon NCT01119274

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Venous thromboembolism, atrial fibrillation requiring coumarin therapy, target inr in the low intensity range
Item
patients with either venous thromboembolism (vte) or atrial fibrillation (af) requiring coumarin therapy for at least 12 weeks and a target inr in the low intensity range (inr range 2-3 in the united kingdom, sweden, germany, austria and greece and inr 2.5-3.5 in the netherlands)
boolean
C1861172 (UMLS CUI [1,1])
C0686904 (UMLS CUI [1,2])
C0010206 (UMLS CUI [1,3])
C0004238 (UMLS CUI [2,1])
C0686904 (UMLS CUI [2,2])
C0010206 (UMLS CUI [2,3])
C1521840 (UMLS CUI [3,1])
C0525032 (UMLS CUI [3,2])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
Ability to attend scheduled visits
Item
ability to attend scheduled visits
boolean
C2827364 (UMLS CUI [1,1])
C0085732 (UMLS CUI [1,2])
Informed consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Presence of a mechanical heart valve
Item
presence of a mechanical heart valve
boolean
C0493527 (UMLS CUI [1])
Severe cognitive impairment
Item
severe cognitive impairment
boolean
C3554639 (UMLS CUI [1])
Known genotype cyp2c9 or vkorc1
Item
known genotype cyp2c9 or vkorc1 at start of the study
boolean
C1332829 (UMLS CUI [1])
C1428184 (UMLS CUI [2])
Previous or current treatment with any coumarin
Item
previous or current treatment with any coumarin
boolean
C0010206 (UMLS CUI [1,1])
C2827774 (UMLS CUI [1,2])
C0010206 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
Pregnancy or lactation
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0022925 (UMLS CUI [2])
Ineligibility
Item
non-eligible subject
boolean
C1512714 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial